TScan Therapeutics, Inc. financial statements
TScan Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 10.32M | 10-K |
| Net income | −USD 129.77M | 10-K |
| Cash and equivalents | USD 152.41M | 10-Q |
| Total debt | USD 32.53M | 10-K |
TScan Therapeutics, Inc. financials on 6ix · TScan Therapeutics, Inc. on 6ix